20mins delayed


1 Year Return

System message

BIG CHANGES! Try the new Market Index

For the best experience, create a free account.

Truscreen Group Ltd Chart

Share price
Market Cap $50.8 million
Today's Movement
Prev. Close
Day Range -
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover

TRU Statistics

15 January

1,311 / 2,260

ASX Size Rank

1yr Return

vs Sector (1yr)


vs ASX 200 (1yr)


$50.8 million

Market Cap

Share Issue

362.87 million

All Ords (%)


Short Sold


Current Fundamentals

15 January


PE Ratio

EPS ($)


Earnings Yield


NTA ($)



Dividend Yield

DPS ($)


Gross Div. Yield


Gross DPS ($)


Company Overview

Truscreen Group Limited (TRU) is the manufacturer and owner of the TruScreen Cervical Cancer Screening System. TruScreen's real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue.

Truscreen Group Ltd Logo

Corporate Details

Head Office: Sydney
Managing Director: Victoria Potarina
GICS Sub-Industry: Health Care Equipment
Date Listed: 6 Jan 2021
Registry: -
Similar Companies: FPH / COH / RMD / ANN / NAN

Upcoming Calendar

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.


Date Heading Pages File Size Time

Announcements provided by

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

TRU is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data

Name Title Since Bio
Mr Anthony (Tony) Peng Ho Non-Executive Chairman, Non-Executive Director Oct 2018
Mr Christopher (Chris) John Lawrence Non-Executive Director Dec 2017
Mr Christopher Horn Non-Executive Director Nov 2013
Ms Juliet Hull Non-Executive Director Sep 2020
Mr Guy Adrian Robertson Chief Financial Officer, Company Secretary Nov 2018
Mrs Victoria Potarina Chief Executive Officer Mar 2020

Director Transactions

About the Data

TRU directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code TRU in our database.

Shareholder Distribution

Shareholder Distribution data is unavailable.

Top 20 Shareholders

About the Data

Name Shares Capital
New Zealand Depository Nominee 30,362,441 8.41%
Consolidated Nominees Pty Ltd (i) 29,539,900 8.18%
New Zealand Central Securities Depository Limited 23,049,754 6.39%
Browns Island Holdings Limited 22,400,000 6.21%
Waitara Trustees Limited 18,622,222 5.16%
Masfen Securities Limited 13,499,645 3.74%
Albert Nominees Limited 11,000,000 3.05%
Consolidated Nominees Pty Ltd (ii) 10,062,500 2.79%
Forsyth Barr Custodians Limited 10,003,610 2.77%
Idl Trustee Limited 9,850,000 2.73%
Maarten Arnold Janssen 4,964,170 1.38%
Ryan Peter Parkin 4,665,428 1.29%
David Russell Stewart & Adrienne Ruth Stewart 4,138,995 1.15%
Melda Super Pty Limited 3,500,000 0.97%
Caroline Robyn Ball & Christopher John Thomson Bush 2,978,681 0.83%
Anthony Peng Ho & Chui Hoong Ho 2,400,000 0.66%
Custodial Services Limited 2,367,499 0.66%
Mark David John Williams 2,321,429 0.64%
Qsp Limited 2,312,790 0.64%
Timothy James Macintosh 2,276,619 0.63%
All other shareholders 41.72 %

The Top 20 Shareholders of TRU hold 58.28% of shares on issue.

TRU Share Price History

Date Close Change % Change Open High Low Volume Turnover

TRU Historical Data

Download up to 20 years of share price history.

Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: The development, manufacture and sale of cancer detection devices and systems.

Incorporated: --

Suite 506, Level 5, 50 Clarence St
Sydney NSW 2000

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.